Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer

Front Oncol. 2019 Dec 17:9:1414. doi: 10.3389/fonc.2019.01414. eCollection 2019.
No abstract available

Keywords: EGFR inhibitiors; RAS; colorectal cancer; ctDNA; liquid biopsy.